Patent · US Active

Peptides for transport of therapeutics and their carriers in mouse models and humans

US8926946B2 · kind B2 · utility

5Cited by
2References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2010
Grant dateJan 6, 2015
Priority date
Expiry dateJun 30, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A system for targeted delivery of agents (e.g., molecular probes, diagnostic agents, therapeutic agents, imaging agents, research or analytical compounds, enzymes, peptides, proteins, lipids, lipoproteins, sugars, hormones, vitamins, nucleic acids, viruses, bacteria, and/or cells) including use of a composition containing the agent and a targeting moiety, specific for a determinant at the target location. An exemplary composition of the system includes a targeting moiety of one of peptides γ3, 2γ3, 3γ3, A1, B7, B8, B9, B1O, and D6, specific for targeting ICAM-I. The system enables effective, versatile, and safe targeting and transport of agents. The system is useful in research applications, as well as in the context of translational science and clinical interventions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.